Emma Nimeus-Malmstrom

Medicon Village
Lund, M 22381, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 43 publications

Investigation of a prostate cancer radiation response signature in the breast cancer SweBCG91RT randomized trial.

Investigation of a prostate cancer radiation response signature in the breast cancer SweBCG91RT randomized trial.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: April 16, 2026

Lateral perforator flap: A surgically and oncologically safe method for patients with breast cancer.

Lateral perforator flap: A surgically and oncologically safe method for patients with breast cancer.

Journal: JPRAS open

Published: March 10, 2026

Tumoral pSMAD2 as a prognostic biomarker in early-stage breast cancer: insights from the randomized SweBCG91RT trial.

Tumoral pSMAD2 as a prognostic biomarker in early-stage breast cancer: insights from the randomized SweBCG91RT trial.

Journal: Breast cancer research and treatment

Published: March 03, 2025

Glucose-6-phosphate-dehydrogenase on old peroxisomes maintains self-renewal of epithelial stem cells after asymmetric cell division.

Glucose-6-phosphate-dehydrogenase on old peroxisomes maintains self-renewal of epithelial stem cells after asymmetric cell division.

Journal: Nature communications

Published: November 06, 2024

Endothelial Cell pY397-FAK Expression Predicts the Risk of Breast Cancer Recurrences after Radiotherapy in the SweBCG91-RT Cohort.

Endothelial Cell pY397-FAK Expression Predicts the Risk of Breast Cancer Recurrences after Radiotherapy in the SweBCG91-RT Cohort.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: September 06, 2024

The potential radiosensitization target PFKFB3 is related to response to radiotherapy in SweBCG91RT: a randomized clinical trial with long-term follow-up.

The potential radiosensitization target PFKFB3 is related to response to radiotherapy in SweBCG91RT: a randomized clinical trial with long-term follow-up.

Journal: BMC cancer

Published: September 06, 2024

Evaluation of alternative prognostic thresholds for SP142 and 22C3 immunohistochemical PD-L1 expression in triple-negative breast cancer: results from a population-based cohort.

Evaluation of alternative prognostic thresholds for SP142 and 22C3 immunohistochemical PD-L1 expression in triple-negative breast cancer: results from a population-based cohort.

Journal: Breast cancer research and treatment

Published: May 28, 2024

The analytical and clinical validity of AI algorithms to score TILs in TNBC: can we use different machine learning models interchangeably?

The analytical and clinical validity of AI algorithms to score TILs in TNBC: can we use different machine learning models interchangeably?

Journal: EClinicalMedicine

Published: May 20, 2024

Human proteome distribution atlas for tissue-specific plasma proteome dynamics.

Human proteome distribution atlas for tissue-specific plasma proteome dynamics.

Journal: Cell

Published: May 14, 2024

Comparison of SP142 and 22C3 PD-L1 assays in a population-based cohort of triple-negative breast cancer patients in the context of their clinically established scoring algorithms.

Comparison of SP142 and 22C3 PD-L1 assays in a population-based cohort of triple-negative breast cancer patients in the context of their clinically established scoring algorithms.

Journal: Breast cancer research : BCR

Published: April 20, 2023

Combining histological grade, TILs, and the PD-1/PD-L1 pathway to identify immunogenic tumors and de-escalate radiotherapy in early breast cancer: a secondary analysis of a randomized clinical trial.

Combining histological grade, TILs, and the PD-1/PD-L1 pathway to identify immunogenic tumors and de-escalate radiotherapy in early breast cancer: a secondary analysis of a randomized clinical trial.

Journal: Journal for immunotherapy of cancer

Published: March 17, 2023

Low levels of WRAP53 predict decreased efficacy of radiotherapy and are prognostic for local recurrence and death from breast cancer: a long-term follow-up of the SweBCG91RT randomized trial.

Low levels of WRAP53 predict decreased efficacy of radiotherapy and are prognostic for local recurrence and death from breast cancer: a long-term follow-up of the SweBCG91RT randomized trial.

Journal: Molecular oncology

Published: November 08, 2022

Showing 1-12 of 43

Last Updated: 09/26/2026